Skip to main content
Signal8

Dunn Gordon

SEC insider (Form 3/4/5 filer). CIK 0001958139. Chief Financial Officer at Quoin Pharmaceuticals, Ltd. (QNRX). 7 reported Form 4/5 transactions since Sep 2024; latest on Dec 23, 2024. Located in ASHBURN, VA.

Companies Dunn Gordon has filed insider reports for

  • Quoin Pharmaceuticals, Ltd. (QNRX): Officer, Chief Financial Officer
Dunn Gordon profile photo

Dunn Gordon

CIK: 0001958139

Transaction Breakdown

Open Market Buys (P)6 (85.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Quoin Pharmaceuticals, Ltd. logo
QNRX

Quoin Pharmaceuticals, Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Quoin Pharmaceuticals, Ltd. logo
    QNRX

    Quoin Pharmaceuticals, Ltd.

    Dec 23, 2024
    Purchase
    Direct
    122.2K shares at avg. $0.45$55K
  • Quoin Pharmaceuticals, Ltd. logo
    QNRX

    Quoin Pharmaceuticals, Ltd.

    Dec 9, 2024
    Award

    Share Option (Right to Buy)

    Direct
    339K shares-
  • Quoin Pharmaceuticals, Ltd. logo
    QNRX

    Quoin Pharmaceuticals, Ltd.

    Sep 10, 2024
    Purchase
    Direct
    10K shares at avg. $0.91$9K
  • Quoin Pharmaceuticals, Ltd. logo
    QNRX

    Quoin Pharmaceuticals, Ltd.

    Sep 10, 2024
    Purchase
    Direct
    10K shares at avg. $0.71$7K
  • Quoin Pharmaceuticals, Ltd. logo
    QNRX

    Quoin Pharmaceuticals, Ltd.

    Sep 9, 2024
    Purchase
    Direct
    4K shares at avg. $0.78$3K
  • Quoin Pharmaceuticals, Ltd. logo
    QNRX

    Quoin Pharmaceuticals, Ltd.

    Sep 9, 2024
    Purchase
    Direct
    4K shares at avg. $0.80$3K
  • Quoin Pharmaceuticals, Ltd. logo
    QNRX

    Quoin Pharmaceuticals, Ltd.

    Sep 9, 2024
    Purchase
    Direct
    856 shares at avg. $0.80$684.8

1-7 of 7